Slow study start-up
Feasibility and site activation often drag on for months. We return data-backed feasibility in 5–7 business days and run ethics and regulatory submissions in parallel.
A dependable execution partner for Phase I–IV studies, medical device investigations and real-world evidence in India.
Running a clinical study in India offers access to large, treatment-naive patient populations, experienced investigators and cost-efficient operations — but only when execution is managed by people who know the system from the inside.
Ethica Research gives sponsors and CROs one accountable partner for feasibility, site selection, regulatory approvals, patient recruitment, site management, monitoring and data. Whether you need a full-service CRO or a reliable site network to complement your own team, we adapt to your operating model.
Feasibility and site activation often drag on for months. We return data-backed feasibility in 5–7 business days and run ethics and regulatory submissions in parallel.
Most delayed trials miss enrollment targets. We build recruitment plans around patient registries, physician referral networks and ethics-approved community outreach from day one.
CDSCO, CTRI and ethics committee requirements change often. Our regulatory specialists manage every submission and query end-to-end.
Sponsors deserve to know where their study stands. Weekly dashboards track enrollment, data entry, open queries and deviations — no surprises.
Participant safety, valid informed consent and data integrity are never traded for speed. Our processes are built around them.
Experienced principal investigators and GCP-certified coordinators run every site, supported by an independent QA function.
Parallel submissions, pre-negotiated site agreements and standard budgets help studies go live sooner.
We co-own timelines with you, escalate early and stay accountable from first contact to final report.
Tell us about your study. A senior member of our clinical operations team will review it and respond within one business day.
We usually deliver a site-by-site feasibility assessment with realistic enrollment projections within five to seven business days of receiving a protocol synopsis under NDA.
Yes. We support pilot, pivotal and post-market clinical investigations of medical devices and in-vitro diagnostics in line with the Medical Devices Rules, 2017.
Absolutely. We regularly act as the local execution partner for international sponsors and CROs, supporting regulatory submissions, site management and monitoring in India.
We operate under a documented quality management system with SOPs, training records, internal audits, CAPA management and regular mock inspections at sites.